Page last updated: 2024-08-26

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and mitomycin

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with mitomycin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durand, RE; Olive, PL1
Adams, GE; Bowler, J; Bremner, JC; Stratford, IJ1
Adams, GE; Godden, J; Keohane, A; Stratford, IJ1
Kennedy, KA1
Adams, GE; Bradley, JK; Bremner, JC; Naylor, MA; Sansom, JM; Stratford, IJ1
Bengmark, S; Persson, BG; Wang, LQ1
Melo, T; Misra, V; Rauth, AM1

Reviews

1 review(s) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and mitomycin

ArticleYear
Hypoxic cells as specific drug targets for chemotherapy.
    Anti-cancer drug design, 1987, Volume: 2, Issue:2

    Topics: Animals; Antineoplastic Agents; DNA Damage; DNA Repair; Humans; Misonidazole; Mitomycin; Mitomycins; Oxygen; Tirapazamine; Triazines

1987

Other Studies

6 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and mitomycin

ArticleYear
Evaluation of bioreductive drugs in multicell spheroids.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Aggregation; Cell Hypoxia; Cell Survival; Cricetinae; Evaluation Studies as Topic; In Vitro Techniques; Misonidazole; Mitomycin; Models, Biological; Nitrofurans; Porfiromycin; Prodrugs; Tirapazamine; Triazines

1992
Bioreductive drugs and the selective induction of tumour hypoxia.
    British journal of cancer, 1990, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Constriction; Hydralazine; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Mitomycins; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tirapazamine; Triazines

1990
The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    British journal of cancer, 1990, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Survival; Misonidazole; Mitomycin; Mitomycins; Radiation Tolerance; Radiation-Sensitizing Agents; Tirapazamine; Triazines

1990
Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT).
    International journal of radiation oncology, biology, physics, 1994, May-15, Volume: 29, Issue:2

    Topics: Animals; Antineoplastic Agents; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Nitroimidazoles; Photochemotherapy; Sarcoma, Experimental

1994
Bioreduction of RSU 1069 and mitomycin C after dearterialization.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1993, Volume: 19, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Chemotherapy, Adjuvant; Hepatic Artery; Humans; Ligation; Liver Neoplasms, Experimental; Male; Misonidazole; Mitomycin; Rats; Rats, Inbred WF

1993
Bioreductive therapies: an overview of drugs and their mechanisms of action.
    International journal of radiation oncology, biology, physics, 1998, Nov-01, Volume: 42, Issue:4

    Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; DNA, Neoplasm; Forecasting; Humans; Indolequinones; Indoles; Misonidazole; Mitomycin; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines

1998